NCT06923475
- Conditions
- Adenocarcinoma, Borderline Resectable, Carcinoma, +9 more
- Locations
-
- Amsterdam University Medical Center Amsterdam, Netherlands
Clinical trial condition
Explore clinical trials studying Borderline Resectable. Study availability and eligibility vary by location and protocol.
NCT06923475